期刊文献+

重症肌无力多次危象的诱因和预后 被引量:5

Predisposing causes and prognosis of multiple myasthenia gravis crisis
下载PDF
导出
摘要 目的探讨重症肌无力多次危象的诱因和预后。方法对65例重症肌无力危象患者(其中11例为多次危象患者)的临床资料进行回顾性分析。结果 11例多次危象患者共发生24次危象,且均有明确诱因,其中以感染(17例次,70.8%)与疲劳紧张(5例次,20.8%)最多见。多次危象组患者经大剂量甲泼尼龙冲击或联合大剂量免疫球蛋白治疗,均取得较好的疗效,预后与单次危象组比较差异无统计学意义。多次危象组患者并发抑郁焦虑状态的比例明显高于单次危象组(P<0.01)。结论重症肌无力多次危象的主要诱因为感染、疲劳紧张等。如避免上述危险因素,加强并发症的防治,并予以适当的心理治疗,重症肌无力多次危象可防可治。 Objective To study the predisposing causes and prognosis of multiple myasthenia gravis crisis (MGC) . Methods Clinical data of 65 patients with MGC (including 11 cases of multiple MGC) were analyzed retrospectively. Results Crisis of 11 patients with multiple MGC happened 24 times. And each time had its predisposing cause. Among which,infection (17 times,70. 8% ) ,fatigue and tension (5 times,20. 8% ) were the most. Patients of multiple MGC group all get good curative effects after large dose of Methyllprednisolone therapy or combination therapy of which and large dose of immune globulin. There was no significant difference of prognosis between multiple MGC group and single MGC group. The proportion of complicating depression and anxiety in multiple MGC group was significantly higher than single MGC group (P 0. 01 ) . Conclusions The main predisposing causes of multiple MGC are infection,fatigue and tension,et al. If avoid above risk factors,enhance the prevention and cure of complication and get right psychotherapy,multiple MGC can be prevented and cured.
出处 《临床神经病学杂志》 CAS 北大核心 2010年第5期335-336,共2页 Journal of Clinical Neurology
关键词 重症肌无力 多次危象 诱因 预后 myasthenia gravis multiple crises predisposing causes prognosis
  • 相关文献

参考文献6

  • 1Tomas C, Mayer S, Gungor Y, et al. Myasthenic crisis: clinical features, mortality, complications and risk factors for prolonged intubation[J]. Neurology, 1997, 48: 1253.
  • 2Elechi CA, Shah A, Lisak RP. Infections occurring in hospitalized myasthenia gravis patients[ J ]. Ann NY Acad Sci, 1993,681:561.
  • 3张晓兰,刘敏,杨祖文.72例重症肌无力死亡原因分析[J].山东医药,2007,47(26):77-78. 被引量:1
  • 4Berrouschot J, Baumann I, Kalischewski P, et al. Therapy of myasthenic crisis[ J ]. Crit Care Med, 1997,25 : 1228.
  • 5Juel VC. Myasthenia gravis: management of myasthenic crisis and perioperative care[ J]. Semin Neurol,2004,24:75.
  • 6王晓芳,丛志强,张本恕,周红梅.重症肌无力患者的死因分析[J].脑与神经疾病杂志,2007,15(1):55-56. 被引量:3

二级参考文献5

  • 1Christensen PB,Jensen TS,Tsiropoulos I,et al.Mortality and survival in myast henia gravis:a Danish population based study.J Neurol Neurosurg Psychiatry,1998;64:78~83
  • 2Vats HS,Richardson SK,Pulukurthy S,et al.Pericarditis in myasthenia gravis[J].Cardiol Rev,2004,12(3):134-137.
  • 3Ahmed S,Kirmani JF,Janjua N,et al.An Update on Myasthenic Crisis[J].Curt Treat Options Neurol,2005,7(2):129-141.
  • 4舒仁荣,秦绍森.9例重症肌无力死因分析[J].脑与神经疾病杂志,2000,8(1):25-27. 被引量:3
  • 5谭兰,刘敏,王雁,丛志强.重症肌无力病人危象82例临床分析[J].中华神经科杂志,2002,35(2):93-95. 被引量:26

共引文献2

同被引文献45

  • 1宋金辉,徐金枝.218例重症肌无力危象的临床分析[J].卒中与神经疾病,2005,12(5):269-271. 被引量:19
  • 2王旭广,杨鲲鹏,寿化山,丁旭青,郭亮.重症肌无力胸腺切除术后发生肌无力危象的危险因素[J].中华胸心血管外科杂志,2006,22(4):268-269. 被引量:14
  • 3宋志芳.现代呼吸机治疗学[M].北京:人民军医出版社.2008:203-209
  • 4Roberts P F,Venuta F, Rendina E, et al. Thymectomy in the treat ment of ocularmyasthenia grabis [J]. J Thorac Card iobasc Surg, 2001, 122(3 ):562.
  • 5Kas J, Kiss D, Simon V, et al. Decade-long exrerience with surgical therapy of muasthenia gravis early complications of 324 transtemal thymeetomies[J]. Ann Thorac Surg, 2001, 72 ( 5 ): 1691.
  • 6Murray S. Bi-level positive airway pressure (BiPAP) and acute car- diogenic pulmonary edema (ACPO) in the energency department [J]. Aust Crit Care, 2002, 15(2):51.
  • 7Kleopa K A, Sherman M, Neal B, et al. BiPAP impoves survival and rate of pulmonary function decline inpatients with AIS [J]. J Neurol Sci, 1999, 164( 1 ):82.
  • 8Simonds A K, Muntoni F, Heather S, et al. Impact of nasal ventila- tion on survival in hyercapnic Duchenne muscular dystrophy [J]. Thorax, 1998, 53( 11 ): 949.
  • 9Pyeron A M. Respiratory failure in the neurological patient:the diag- nosis of neurofenic pulmonary edema[J]. J Neurosci Nurs, 2001, 33 (4):203.
  • 10Kondo K. Optimal therapy for thymoma [ J]. J Med Invest, 2008, 55 : 17 - 28.

引证文献5

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部